Molecular Diagnostics Companies

Top Industry Leaders in the Molecular Diagnostics Market

*Disclaimer: List of key companies in no particular orderLatest Molecular diagnostics Companies Update

Sep 2023: A final agreement has been reached for the transfer of ownership of Resolution Bioscience to Exact Sciences, a prominent supplier of diagnostic and screening tests for cancer, between Agilent Technologies, Inc., and Exact Sciences Corp. For $695 million, Agilent Technologies purchased Resolution Bioscience Inc., a pioneer in the formation and marketing of precision oncology treatments based on next-generation sequencing (NGS). The acquisition enhanced and expanded Agilent's capabilities in NGS-based cancer diagnostics, giving the business access to front-line technology to better meet the demands of the rapidly expanding precision medicine sector. Resolution Bioscience is a strategic fit for Exact, a leading central laboratory for cancer-related diagnostic testing with substantial expertise and resources. An excellent result of this transaction will be that the skilled Resolution Bioscience team will be able to go on developing diagnostic remedies for their clients and patients thanks to this agreement.

Jul 2023: Becton Dickinson's stock reached a record high on Monday and was recently up 6.1% following the medical device manufacturer's approval by the US Food and Drug Administration to take its drug infusion system back to the market late on Friday. Over three years ago, the company recalled a portion of the Alaris pumps because of worries that they would cause medicine to be accidentally, more quickly, or slowly delivered than planned. According to Becton Dickinson, it anticipates shipping the devices and making money in 2024. As of September 30, 2023, it stated that it does not anticipate receiving any significant additional revenue from the Alaris infusion system during the remainder of the fiscal year.

List of Molecular diagnostics Key companies in the market